Aptabio Therapeutics
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Heungdeok It Valley 504 Heungdeok 1-ro G...Phone Number
+82 313653693Website
www.aptabio.comRevenue
$7.1 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Aptabio Therapeutics
AptaBio is a specialized company focused on the development of First-in-Class drugs based on platform technology, targeting treatments for unmet medical needs in difficult-to-treat diseases such as inflammation, fibrosis, and cancer. The company aims to provide new hope to patients suffering from these conditions by developing innovative therapies that effectively modulate oxidative stress and enhance the efficacy of immuno-oncology agents. AptaBio is committed to growing as a global enterprise by continuously developing competitive pipelines in the global market. Their mission is encapsulated in their name, which reflects their dedication to creating therapies that fit well for patients.Explore more
Popular SearchesAptaBio Therapeutics IncAptaBioSIC Code 87,873NAICS Code 54,541Show moreAptabio Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aptabio Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Aptabio Therapeutics
Funding: Get notified immidiatlly once Aptabio Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Aptabio Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Aptabio Therapeutics is spiking on competitors!
Click to see if Aptabio Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Aptabio Therapeutics recently announced quarterly report
Aptabio Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Aptabio Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Aptabio Therapeutics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Aptabio Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aptabio Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aptabio Therapeutics.
Aptabio Therapeutics Tech Stack
A closer look at the technologies used by Aptabio Therapeutics
See more technologies
Aptabio Therapeutics News & Media
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aptabio Therapeutics
Sign Up For FreeTo access detailed company insights
AptaBio is a specialized company focused on the development of First-in-Class drugs based on platform technology, targeting treatments for unmet medical needs in difficult-to-treat diseases such as inflammation, fibrosis, and cancer. The company aims to provide new hope to patients suffering from these conditions by developing innovative therapies... Read More
